113 related articles for article (PubMed ID: 27658340)
1. Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol.
Testi AM; Moleti ML; Canichella M; Mohamed S; Diverio D; de Propris MS; Locatelli F; Lo Coco F; Foà R
Leuk Lymphoma; 2017 Apr; 58(4):999-1001. PubMed ID: 27658340
[No Abstract] [Full Text] [Related]
2. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
[TBL] [Abstract][Full Text] [Related]
3. Optimal approach for high-risk acute promyelocytic leukemia.
Iland HJ; Seymour JF; Wei A
Curr Opin Hematol; 2014 Mar; 21(2):102-13. PubMed ID: 24378704
[TBL] [Abstract][Full Text] [Related]
4. Testicular relapse of acute promyelocytic leukemia after allogeneic BMT.
Forrest DL; Dalal BI; Naiman SC; Horsman DE; Berry BR; Parslow MI; Singh CP; Benny WB; Barnett MJ
Bone Marrow Transplant; 1997 Oct; 20(8):689-90. PubMed ID: 9383233
[TBL] [Abstract][Full Text] [Related]
5. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute promyelocytic leukemia.
Elbahesh E; Patel N; Tabbara IA
Anticancer Res; 2014 Apr; 34(4):1507-17. PubMed ID: 24692677
[No Abstract] [Full Text] [Related]
7. Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.
Mueller BU; Buerger AU; Solenthaler M; Garamvoelgyi EM; Oppliger-Leibundgut E; Fey MF; Pabst T
Ann Oncol; 2006 Apr; 17(4):722-3. PubMed ID: 16291581
[No Abstract] [Full Text] [Related]
8. [Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)].
Franke M; Theurich S; Beyer F; Persigehl T
Rofo; 2014 Jun; 186(6):615-7. PubMed ID: 24347358
[No Abstract] [Full Text] [Related]
9. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
Lachaine J; Mathurin K; Barakat S; Couban S
Eur J Haematol; 2015 Sep; 95(3):218-29. PubMed ID: 25354894
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia.
Chung CY; Hsu NC; Horng HC; Chang CS
Leuk Lymphoma; 2003 Jun; 44(6):1059-61. PubMed ID: 12854910
[TBL] [Abstract][Full Text] [Related]
11. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
[TBL] [Abstract][Full Text] [Related]
12. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
[TBL] [Abstract][Full Text] [Related]
14. JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).
Asou N; Fujita H; Shinagawa K
Int J Hematol; 2017 Oct; 106(4):459-470. PubMed ID: 28856623
[No Abstract] [Full Text] [Related]
15. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
16. Late relapses in acute promyelocytic leukaemia.
Latagliata R; Carmosino I; Breccia M; Minni A; Testi A; Iorio N; Lo-Coco F; Avvisati G; Petti MC; Mandelli F; Cimino G
Acta Haematol; 2007; 117(2):106-8. PubMed ID: 17135723
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
18. Management of acute promyelocytic leukemia relapse in the ATRA era.
Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
[TBL] [Abstract][Full Text] [Related]
19. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
Fenaux P; Chastang C; Chomienne C; Castaigne S; Sanz M; Link H; Löwenberg B; Fey M; Archim-Baud E; Degos L
Leuk Lymphoma; 1995 Feb; 16(5-6):431-7. PubMed ID: 7787753
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide consolidation in APL.
Das M
Lancet Oncol; 2017 Sep; 18(9):e517. PubMed ID: 28803794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
